NCT05337202

the Dutch-GERAF Study

The Dutch Multicentre Study Into Opportunistically Screening Geriatric Patients for Atrial Fibrillation Using a PPG Smartphone App; the Dutch-GERAF Study

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 1,075 (actual)
• Sponsor: Dijklander Ziekenhuis · Academic / Other
• Sex: All
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

Geriatric patients are at high risk of cardiovascular complications, and for the development of atrial fibrillation. Often atrial fibrillation exists in these patients without specific symptoms, and could therefore remain unknown. Furthermore, concerns exist about the bleeding profile of anticoagulation in the very elderly or frail patients. This study applies opportunistic screening for atrial fibrillation as advised in the latest ESC Guideline on the diagnosis and management of atrial fibrillation. Furthermore, multiple bleeding risk scores will be applies, to better assess the bleeding risk in very elderly or frail patients.

Conditions

• Atrial Fibrillation
• Frailty
• Major Bleed

Interventions

Type	Name	Description
DEVICE	HeartSDK	The photoplethysmography (PPG) application enables patients to perform a finger tip heartbeat measurement and automatic analysis

Timeline

• Start date: 2021-01-25
• Primary completion: 2022-10-26
• Completion: 2026-06-30
• First posted: 2022-04-20
• Last updated: 2024-02-20

Locations

6 sites across 1 country: Netherlands